In response to: Multiple assays in a real-time RT-PCR severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
作者信息
Peñarrubia Luis, Ruiz Maria, Porco Roberto, Rao Sonia N, Vella Stephen A, Juanola-Falgarona Martí, Manissero Davide, López-Fontanals Marta, Pareja Josep
机构信息
STAT-Dx Life, S.L. (a QIAGEN Company), Barcelona, Spain.
QIAGEN, Inc., Germantown, MD, USA.
出版信息
Int J Infect Dis. 2021 Apr;105:241-242. doi: 10.1016/j.ijid.2021.01.049. Epub 2021 Jan 27.
Abstract
摘要
相似文献
1
In response to: Multiple assays in a real-time RT-PCR severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.回应：在2019冠状病毒病疫情期间，实时逆转录聚合酶链反应严重急性呼吸综合征冠状病毒2（SARS-CoV-2）检测板中的多种检测方法可降低新基因组变异导致敏感性丧失的风险。
Int J Infect Dis. 2021 Apr;105:241-242. doi: 10.1016/j.ijid.2021.01.049. Epub 2021 Jan 27.
2
Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.实时 RT-PCR SARS-CoV-2 检测 panel 中的多重检测可以降低新型基因组变异导致的检测敏感性降低的风险，从而应对 COVID-19 大流行。
Int J Infect Dis. 2020 Aug;97:225-229. doi: 10.1016/j.ijid.2020.06.027. Epub 2020 Jun 12.
3
An Ultra-Rapid Real-Time RT-PCR Method Using the PCR1100 to Detect Severe Acute Respiratory Syndrome Coronavirus-2.一种使用 PCR1100 的超快实时 RT-PCR 方法来检测严重急性呼吸综合征冠状病毒-2。
Jpn J Infect Dis. 2021 Jan 22;74(1):29-34. doi: 10.7883/yoken.JJID.2020.324. Epub 2020 Jun 30.
4
Sinonasal manifestations and dynamic profile of RT-PCR results for SARS-CoV-2 in COVID-19 patients.COVID-19患者中SARS-CoV-2的鼻鼻窦表现及RT-PCR结果的动态变化
Ann Palliat Med. 2021 Apr;10(4):4174-4183. doi: 10.21037/apm-20-2493. Epub 2021 Mar 23.
5
A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).一种逆转录重组酶辅助扩增检测法，用于快速检测严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的 N 基因。
Virology. 2020 Oct;549:1-4. doi: 10.1016/j.virol.2020.07.006. Epub 2020 Jul 29.
6
Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.无症状大学生中使用逆转录-定量聚合酶链反应或基于 CRISPR 的检测方法筛查严重急性呼吸综合征冠状病毒 2 的比较。
JAMA Netw Open. 2021 Feb 1;4(2):e2037129. doi: 10.1001/jamanetworkopen.2020.37129.
7
Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand.利用基因组学追踪冠状病毒病疫情，新西兰。
Emerg Infect Dis. 2021 May;27(5):1317-1322. doi: 10.3201/eid2705.204579.
8
Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR.实时 RT-PCR 对呼吸道样本进行快速批量筛查 COVID-19。
Emerg Infect Dis. 2020 Oct;26(10):2469-2472. doi: 10.3201/eid2610.201955. Epub 2020 Aug 26.
9
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
10
Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.七种用于 COVID-19 的商业 RT-PCR 诊断试剂盒的比较。
J Clin Virol. 2020 Jul;128:104412. doi: 10.1016/j.jcv.2020.104412. Epub 2020 May 8.
引用本文的文献
1
Molecular diagnostics using the QIAstat-Dx syndromic device for covering avian influenza pandemic preparedness.使用QIAstat-Dx综合征检测设备进行分子诊断以应对禽流感大流行防范。
Heliyon. 2024 Nov 26;10(23):e40645. doi: 10.1016/j.heliyon.2024.e40645. eCollection 2024 Dec 15.
2
Monitoring SARS-CoV-2 genetic variability: A post-market surveillance workflow for combined bioinformatic and laboratory evaluation of commercial RT-PCR assay performance.监测 SARS-CoV-2 遗传变异：用于商业 RT-PCR 检测性能的联合生物信息学和实验室评估的上市后监测工作流程。
PLoS One. 2024 Jan 12;19(1):e0294271. doi: 10.1371/journal.pone.0294271. eCollection 2024.
3
Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.mRNA、腺病毒载体和灌注蛋白 COVID-19 疫苗的功效。
Biomed Pharmacother. 2022 Feb;146:112527. doi: 10.1016/j.biopha.2021.112527. Epub 2021 Dec 10.
4
Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2.龙牙草、五倍子及其成分抗 SARS-CoV-2 的强效抗病毒活性。
Bioorg Med Chem. 2021 Sep 1;45:116329. doi: 10.1016/j.bmc.2021.116329. Epub 2021 Jul 23.
5
Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19.新冠病毒动力学及实时逆转录聚合酶链反应（RT-PCR）Ct值与COVID-19疾病严重程度的相关性
Diagnostics (Basel). 2021 Jun 15;11(6):1091. doi: 10.3390/diagnostics11061091.
6
Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.SARS-CoV-2 不同变体的特征及其相关发病率和死亡率：系统评价。
Eur J Med Res. 2021 Jun 8;26(1):51. doi: 10.1186/s40001-021-00524-8.
本文引用的文献
1
S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.S 变异株 SARS-CoV-2 谱系 B1.1.7 与 TaqPath 聚合酶链反应检测样本中的病毒载量显著升高相关。
J Infect Dis. 2021 May 28;223(10):1666-1670. doi: 10.1093/infdis/jiab082.
2
Fast-spreading U.K. virus variant raises alarms.传播迅速的英国病毒变种引发警报。
Science. 2021 Jan 1;371(6524):9-10. doi: 10.1126/science.371.6524.9.
3
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.没有证据表明 SARS-CoV-2 反复出现的突变会增加传染性。
Nat Commun. 2020 Nov 25;11(1):5986. doi: 10.1038/s41467-020-19818-2.
4
Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.实时 RT-PCR SARS-CoV-2 检测 panel 中的多重检测可以降低新型基因组变异导致的检测敏感性降低的风险，从而应对 COVID-19 大流行。
Int J Infect Dis. 2020 Aug;97:225-229. doi: 10.1016/j.ijid.2020.06.027. Epub 2020 Jun 12.
Zotero 插件